Literature DB >> 26228128

CANCER. A p53-regulated immune checkpoint relevant to cancer.

Laurence Zitvogel1, Guido Kroemer2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26228128     DOI： 10.1126/science.aac8475

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  13 in total

1.  Subversion of anticancer immunosurveillance by radiotherapy.

Authors:  Laurence Zitvogel; Guido Kroemer
Journal:  Nat Immunol       Date:  2015-10       Impact factor: 25.606

Review 2.  Clearance of Dying Cells by Phagocytes: Mechanisms and Implications for Disease Pathogenesis.

Authors:  Aaron M Fond; Kodi S Ravichandran
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

3.  TP53 mutation-associated immune infiltration and a novel risk score model in HNSCC.

Authors:  Weili Kong; Yinze Han; Hailing Gu; Hui Yang; Yi Zang
Journal:  Biochem Biophys Rep       Date:  2022-10-13

Review 4.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

Review 5.  Relevance of the p53-MDM2 axis to aging.

Authors:  Danyi Wu; Carol Prives
Journal:  Cell Death Differ       Date:  2017-12-01       Impact factor: 15.828

6.  Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration.

Authors:  Ayman Oweida; Mohammad K Hararah; Andy Phan; David Binder; Shilpa Bhatia; Shelby Lennon; Sanjana Bukkapatnam; Benjamin Van Court; Nomin Uyanga; Laurel Darragh; Hyun Min Kim; David Raben; Aik Choon Tan; Lynn Heasley; Eric Clambey; Raphael Nemenoff; Sana D Karam
Journal:  Clin Cancer Res       Date:  2018-07-24       Impact factor: 12.531

7.  Immunogenomics Analysis Reveals that TP53 Mutations Inhibit Tumor Immunity in Gastric Cancer.

Authors:  Zehang Jiang; Zhixian Liu; Mengyuan Li; Cai Chen; Xiaosheng Wang
Journal:  Transl Oncol       Date:  2018-07-27       Impact factor: 4.243

8.  TP53 Mutations Promote Immunogenic Activity in Breast Cancer.

Authors:  Zhixian Liu; Zehang Jiang; Yingsheng Gao; Lirui Wang; Cai Chen; Xiaosheng Wang
Journal:  J Oncol       Date:  2019-06-02       Impact factor: 4.375

9.  A Comprehensive Pan-Cancer Analysis of RBM8A Based on Data Mining.

Authors:  Nan Mei; Heyan Chen; Ni Zhao; Ye Yi; Chunli Li
Journal:  J Oncol       Date:  2021-07-06       Impact factor: 4.375

10.  KDM5A Regulates a Translational Program that Controls p53 Protein Expression.

Authors:  Dongli Hu; Carolyn Jablonowski; Pei-Hsin Cheng; Alaa AlTahan; Chunliang Li; Yingdi Wang; Lance Palmer; Cuixia Lan; Bingmei Sun; Ahmed Abu-Zaid; Yiping Fan; Mark Brimble; Nicolas T Gamboa; Ramhari C Kumbhar; David Yanishevski; Kyle M Miller; Guolian Kang; Gerard P Zambetti; Taosheng Chen; Qin Yan; Andrew M Davidoff; Jun Yang
Journal:  iScience       Date:  2018-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.